Stocks · News reference
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients in the exploratory cohortTopline results of NATiV3 expected in Q4 2026September investor conference
U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Monday. Shares of Pinterest, Inc. (NYSE:PINS) fell sharply in pre-market trading following the announcement that CFO Julia Brau